Literature DB >> 2275326

Clonidine premedication: a useful adjunct in producing deliberate hypotension.

J Toivonen1, S Kaukinen.   

Abstract

The effect of clonidine on the dose requirements of labetalol and isoflurane for hypotension was studied in 20 adult patients undergoing middle-ear surgery. Group I (10 patients) received as premedication only pethidine 1 mg.kg-1 i.m., and Group II (10 patients) clonidine 4-5 micrograms.kg-1 p.o. in addition to pethidine. Fentanyl was used for analgesia and d-tubocurarine for muscle relaxation. The dose of labetalol required to induce hypotension to the mean arterial pressure (MAP) 50 mmHg (6.7 kPa) was 0.85 +/- 0.08 mg.kg-1 in Group I, and 0.56 +/- 0.08 mg.kg-1 in Group II (P less than 0.05). The mean isoflurane concentration in inspiratory gas for the maintenance of hypotension was 0.8 +/- 0.1 vol% in Group I, and 0.6 +/- 0.1 vol% in Group II (P less than 0.05). Before hypotension, MAP decreased significantly in Group II, and the heart rate (HR) decreased in both groups. There were no significant differences in MAP and HR between the groups during any phase. Urine flow rates (UF) were lower in Group II (0.23 +/- 0.04 ml.min-1) than in Group I (0.68 +/- 0.16 ml.min-1) before hypotension (P less than 0.05) and during hypotension (0.08 +/- 0.02 ml.min-1 vs. 0.68 +/- 0.32 ml.min-1, P less than 0.05). After anaesthesia, there was no difference in UF between the groups. The results indicate that clonidine can be used for deliberate hypotension to decrease the dose requirements of labetalol and isoflurane.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2275326     DOI: 10.1111/j.1399-6576.1990.tb03166.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  10 in total

1.  Alpha-2 agonists and anaesthesia.

Authors:  B Milne
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

2.  The effect of oral clonidine premedication on blood loss and the quality of the surgical field during endoscopic sinus surgery: a placebo-controlled clinical trial.

Authors:  Masood Mohseni; Amin Ebneshahidi
Journal:  J Anesth       Date:  2011-05-18       Impact factor: 2.078

3.  Hypotensive anaesthesia and bleeding during endoscopic sinus surgery: an observational study.

Authors:  A Cardesín; C Pontes; R Rosell; Y Escamilla; J Marco; M J Escobar; M Bernal-Sprekelsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-20       Impact factor: 2.503

4.  Clonidine premedication for induced hypotension with total intravenous anaesthesia for middle ear microsurgery.

Authors:  M Maroof; R M Khan; T H Bhatti
Journal:  Can J Anaesth       Date:  1994-02       Impact factor: 5.063

Review 5.  Controlled hypotension: a guide to drug choice.

Authors:  Christian-Serge Degoute
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Dexmedetomidine used to provide hypotensive anesthesia during middle ear surgery.

Authors:  Farah Nasreen; Shahjahan Bano; Rashid Manzoor Khan; Syed Abrar Hasan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2009-09-27

Review 7.  Controlled hypotension in children: a critical review of available agents.

Authors:  Joseph D Tobias
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

8.  Premedication with oral clonidine decreases intraoperative bleeding and provides hemodynamic stability in cesarean section.

Authors:  Amin Ebneshahidi; Masood Mohseni
Journal:  Anesth Pain Med       Date:  2011-07-01

9.  Effect of clonidine premedication on blood loss in spine surgery.

Authors:  Zahra Taghipour Anvari; Nader Afshar-Fereydouniyan; Farnad Imani; Mojgan Sakhaei; Babak Alijani; Masood Mohseni
Journal:  Anesth Pain Med       Date:  2012-04-01

10.  Effects of Clonidine Premedication on Intraoperative Blood Loss in Patients With and Without Opium Addiction During Elective Femoral Fracture Surgeries.

Authors:  Davood Ommi; Houman Teymourian; Alireza Zali; Farzad Ashrafi; Morteza Jabbary Moghaddam; Alireza Mirkheshti
Journal:  Anesth Pain Med       Date:  2015-08-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.